ESR1 and breast carcinoma: Moreover, tumor subtype has been shown to influence the local stem cell populations in adjacent normal epithelia in breast cancer, where triple-negative tumors contained CD44+CD49f+CD133/2+ stem cells in nine out of nine samples, while in estrogen receptor (ER)-positive tumors, this was detected in only 7 out of 52 samples examined (33).